While some anti-aging therapies, such as hormone replacement, also target bone mass and skeletal health by influencing hormone levels like estrogen, testosterone, and growth hormone, copper peptides primarily focus on skin rejuvenation
Her research has been instrumental in establishing the clinical profile of next-generation metabolic therapies and advancing understanding of multi-receptor agonist approaches to obesity treatment
Legitimate Research Directions: Some peptides DO have potential and are being properly studied: Thymosin Alpha-1: Immune support (approved in 35+ countries, trials in US) BPC-157: IF proper human trials ever happen LL-37: Antimicrobial applications Others: Many peptides have theoretical promise But ONLY if studied properly: Randomized controlled trials Safety studies FDA approval process Medical supervision The Problem: Most "wellness peptides" will NEVER go through this process because: They can't be patented (no profit incentive) Companies would rather sell in gray market Proper trials cost $100M+ If trials show they DON'T work, the market disappears So we're stuck in limbo: promising animal data, zero human data, aggressive marketing
After 5 sessions: 26.5% median hair regrowth, 93% shedding reduction, zero adverse events (Kuceki et al., 2025)